- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Patent holdings for IPC class A61K 35/742
Total number of patents in this class: 1189
10-year publication summary
|
48
|
96
|
115
|
112
|
161
|
162
|
169
|
152
|
146
|
51
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Seres Therapeutics, Inc. | 111 |
40 |
| The University of Tokyo | 3903 |
33 |
| Finch Therapeutics Holdings, LLC | 71 |
30 |
| Novozymes A/S | 3314 |
25 |
| Sami Labs Limited | 114 |
22 |
| Native Microbials, Inc. | 58 |
19 |
| Vedanta Biosciences, Inc. | 42 |
17 |
| Evonik Operations GmbH | 3879 |
16 |
| Pendulum Therapeutics, Inc. | 37 |
15 |
| Microbial Discovery Group, LLC | 57 |
14 |
| NCH Corporation | 266 |
14 |
| School Corporation, Azabu Veterinary Medicine Educational Institution | 51 |
14 |
| The Regents of the University of California | 18943 |
13 |
| Church & Dwight Co., Inc. | 1845 |
13 |
| Ganeden Biotech, Inc. | 61 |
13 |
| Seed Health, Inc. | 135 |
12 |
| Rebiotix, Inc. | 42 |
11 |
| Chr. Hansen A/S | 979 |
9 |
| Société des Produits Nestlé S.A. | 9672 |
8 |
| The Johns Hopkins University | 5377 |
8 |
| Other owners | 843 |